Nusinersen (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nusinersen" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

3doi.org

2^nd place

5^th place

3nih.gov

4^th place

8^th place

2worldcat.org

5^th place

10^th place

2fda.gov

447^th place

409^th place

1who.int

195^th place

64^th place

1springer.com

274^th place

310^th place

1europa.eu

68^th place

28^th place

1kclj.si

low place

238^th place

1web.archive.org

1^st place

2^nd place

1sps.nhs.uk

low place

1sciencedirectassets.com

low place

doi.org

Ottesen, Eric W. (1. januar 2017). »ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy«. Translational Neuroscience (v angleščini). 8 (1): 1–6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976.
»New warning of nusinersen-related communicating hydrocephalus«. Reactions Weekly (v angleščini). 1714 (1): 3. 1. avgust 2018. doi:10.1007/s40278-018-50183-2. ISSN 1179-2051.
Zanetta, C; Nizzardo, M; Simone, C; Monguzzi, E; Bresolin, N; Comi, GP; Corti, S (1. januar 2014). »Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials«. Clinical Therapeutics. 36 (1): 128–140. doi:10.1016/j.clinthera.2013.11.006. PMID 24360800.

europa.eu

ema.europa.eu

https://www.ema.europa.eu/en/documents/product-information/spinraza-epar-product-information_sl.pdf Povzetek glavnih značilnosti zdravila Spinraza, vpogled: 9. 10. 2019.

fda.gov

accessdata.fda.gov

»Nusinersen US Label« (PDF). FDA. december 2016.{{navedi splet}}: Vzdrževanje CS1: samodejni prevod datuma (povezava) Posodobljeni podatki so na strani: FDA index page for NDA 209531

fda.gov

https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-spinal-muscular-atrophy, vpogled: 9. 10. 2019.

kclj.si

https://www.kclj.si/dokumenti/spm_Na_Pediatricni_kliniki_priceli_z_zdravljenjem_otroka_s_SMA_tip_I_07032017.pdf, vpogled: 9. 10. 2019

nih.gov

pubmed.ncbi.nlm.nih.gov

Ottesen, Eric W. (1. januar 2017). »ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy«. Translational Neuroscience (v angleščini). 8 (1): 1–6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976.
Zanetta, C; Nizzardo, M; Simone, C; Monguzzi, E; Bresolin, N; Comi, GP; Corti, S (1. januar 2014). »Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials«. Clinical Therapeutics. 36 (1): 128–140. doi:10.1016/j.clinthera.2013.11.006. PMID 24360800.

ncbi.nlm.nih.gov

Ottesen, Eric W. (1. januar 2017). »ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy«. Translational Neuroscience (v angleščini). 8 (1): 1–6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976.

sciencedirectassets.com

pdf.sciencedirectassets.com

Peng Wen Pao; Keng Boon Wee; Woon Chee Yee; Zacharias Aloysius DwiPramono (april 2014). »Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene« (PDF). Molecular Therapy. 22 (4): 854–861.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava) Zaporedje za nusinersen (UCACUUUCAUAAUGCUGG) je navedeno pod N1-Hua v Tabeli I.

springer.com

adisinsight.springer.com

»Nusinersen«. AdisInsight. Pridobljeno 1. januarja 2017.

sps.nhs.uk

»Nusinersen«. UK Specialist Pharmacy Service. Arhivirano iz prvotnega spletišča dne 13. aprila 2019. Pridobljeno 31. decembra 2016.

web.archive.org

»Nusinersen«. UK Specialist Pharmacy Service. Arhivirano iz prvotnega spletišča dne 13. aprila 2019. Pridobljeno 31. decembra 2016.

who.int

»International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 74« (PDF). World Health Organization. str. 413–414. Pridobljeno 13. marca 2017.

worldcat.org

Ottesen, Eric W. (1. januar 2017). »ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy«. Translational Neuroscience (v angleščini). 8 (1): 1–6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976.
»New warning of nusinersen-related communicating hydrocephalus«. Reactions Weekly (v angleščini). 1714 (1): 3. 1. avgust 2018. doi:10.1007/s40278-018-50183-2. ISSN 1179-2051.